Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/28262
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shabani, Ilir | en_US |
dc.contributor.author | Gavrilovski, Antonio | en_US |
dc.contributor.author | Velkovski, Vilijam | en_US |
dc.contributor.author | Atanasov, Nenad | en_US |
dc.contributor.author | Memeti, Shaban | en_US |
dc.contributor.author | Belchishta, Anila | en_US |
dc.date.accessioned | 2023-10-18T12:26:34Z | - |
dc.date.available | 2023-10-18T12:26:34Z | - |
dc.date.issued | 2021-06-20 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.12188/28262 | - |
dc.description.abstract | The development of aloarthroplasty of the hip is continuously rising. After implantation of a total cement-free hip endoprosthesis, often there is a periprosthetic femoral bone loss. Alendronate has been shown to be a potent inhibitor of bone resorption activity; it inhibits osteoclastic bone resorption, increases bone mass, and plays a significant role in post-implantation stabilization of the femur. The aim of this study was to determine the effect of alendronate on osteointegration of hip endoprosthesis.Material and methods: The study analyzed 10 patients operated on with implantation of a total cement-free hip endoprosthesis (THP). The included patients were examined by a radiographic method at 6 and 12 months and DXA method at 6 and 12 months. Results: The study showed differences in the values of bone mineral density and bone mineral content in the interval between 6 and 12 months in patients undergoing THP, and hence we can conclude that alendronate therapy after THP implantation reduced periprosthetic loss of bone mass and implant stiffening. Alendronate is a proven inhibitor of periprosthetic bone loss that occurs after prirmary impantation of a total cement-free hip endoprosthesis. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Scientific Foundation SPIROSKI | en_US |
dc.relation.ispartof | Archives of Public Health | en_US |
dc.title | Influence of alendronate therapy on the results of densitometric examination after implantation of total hip endoprosthesis | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.3889/aph.2021.5994 | - |
dc.identifier.url | https://www.id-press.eu/aph/article/download/5994/5481 | - |
dc.identifier.url | https://www.id-press.eu/aph/article/download/5994/5488 | - |
dc.identifier.url | https://www.id-press.eu/aph/article/download/5994/5481 | - |
dc.identifier.volume | 13 | - |
dc.identifier.issue | 1 | - |
dc.identifier.fpage | 32 | - |
dc.identifier.lpage | 38 | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
crisitem.author.dept | Faculty of Medicine | - |
crisitem.author.dept | Faculty of Medicine | - |
Appears in Collections: | Faculty of Medicine: Journal Articles |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.